Eli Lilly received approval for a plant development in Pennsylvania and paid a milestone payment to Nxera Pharma.

The entities involved

• Pennsylvania →

  state of the United States of America

  • Leadership efforts are underway in Pennsylvania to secure a trifecta in the state legislature while funding and rebuilding a key organization.Sun 21:23
  • Multiple candidates are running in Pennsylvania, including Bob Brooks, Brian Fitzpatrick, and Janelle Stelson, amidst Republican efforts against Democrats.Sun 20:51
• Eli Lilly and Company →

  American pharmaceutical company

  • Eli Lilly and Novo Nordisk are competing for market share in the weight loss drug sector.Sun 16:06
  • AbbVie, Eli Lilly, and Merck are broadening their therapeutic reach.Sun 10:21
• Nxera Pharma →

  company in Tokyo, Japan

  Nothing else this week.

Related events

• Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.Aug 5
• Eli Lilly and Company received full FDA approval, expanded a safety study into India, and broke ground on a new facility in Houston while competing in the GLP-1 market.Sep 23
• Eli Lilly and AstraZeneca are involved in drug development and market competition, with the FDA issuing approvals and legal actions involving both companies.Oct 7
• Eli Lilly and Company met with the Lebanon city council and announced plans for construction and local funding.Oct 13
• Eli Lilly and Company acquired Point and established a supply agreement with EUZ.Oct 19